Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians

被引:5
|
作者
Dmytrzak, Andrzej [1 ]
Boron, Agnieszka [2 ]
Loniewska, Beata [3 ]
Lewandowska, Klaudyna [2 ]
Goracy, Iwona [2 ]
Kaczmarczyk, Mariusz [2 ]
Ciechanowicz, Andrzej [2 ]
机构
[1] Aesthet Med Andrzej Dmytrzak Prywatne Ctr Chirurg, Ul Niedzialkowskiego 47, PL-71403 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Clin & Mol Biochem, Al Powstancow Wlkp 72, PL-70111 Szczecin, Poland
[3] Pomeranian Med Univ, Dept Neonatal Dis, Ul Powstancow Wlkp 72, PL-70111 Szczecin, Poland
关键词
POLYMORPHIC VARIANTS; COLORECTAL-CANCER; P53; ASSOCIATION; HAPLOTYPES; APOPTOSIS; RISK;
D O I
10.1155/2019/6179063
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction. Keloid is defined as a benign proliferative scar that grows beyond the confines of the original insult to the skin, invading into adjacent normal tissue. The pathogenesis of keloid is complex, and many evidences suggest the influence of genetic factors, among them the polymorphisms of the TP53 gene encoding tumor protein p53. Objective. To investigate the association of rs1042522 (c.215G>C, p.Arg72Pro) and rs17878362 (16-bp insertion/duplication in intron 3) variants, two most frequently analyzed TP53 functional polymorphisms and the risk of keloid in Polish patients. Materials and Methods. The rs1042522 and rs17878362 polymorphisms were identified by sequencing genomic DNA extracted from peripheral blood leukocytes of 86 keloid patients and from cordial blood leukocytes of 100 newborn infants consisting control group. Results. The rs1042522 and rs17878362 TP53 genotype distributions both in keloid patients and in the control group conformed to the expected Hardy-Weinberg equilibrium. No significant differences in the distribution of rs1042522 and rs17878362 TP53 alleles or genotypes have been found between keloid patients and newborn controls. There is tight, but not complete, linkage disequilibrium between rs1042522 and rs17878362 TP53 polymorphisms (D ' = 0.667, r = 0.448, and p=0). No significant differences in the distribution of rs1042522 and rs17878362 TP53 haplotypes or diplotypes have been found between keloid patients and newborn controls. Conclusions. Our results suggest the lack of association of rs1042522 and rs17878362 TP53 polymorphisms and their haplotypes or diplotypes with the susceptibility to keloid scarring in Polish patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Common genetic variants in the TP53 pathway and their impact on cancer
    Barnoud, Thibaut
    Parris, Joshua L. D.
    Murphy, Maureen E.
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (07) : 578 - 585
  • [2] The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants
    Lazarian, Gregory
    Theves, Floriane
    Hormi, Myriam
    Eclache, Virginie
    Poulain, Stephanie
    Bidet, Audrey
    Pastoret, Cedric
    Veronese, Lauren
    Delabesse, Eric
    Estienne, Marie-Helene
    Nadal, Nathalie
    Davi, Frederic
    Nguyen-Khac, Florence
    Lode, Laurence
    Sujobert, Pierre
    Naguib, Dina
    Raynaud, Sophie
    Giraudier, Stephane
    Kosmider, Olivier
    Etancelin, Pascaline
    Cornillet-Lefebvre, Pascale
    Miguet, Laurent
    Leblond, Veronique
    Letestu, Remi
    Soussi, Thierry
    Cymbalista, Florence
    Baran-Marszak, Fanny
    BLOOD, 2019, 134
  • [3] Functional characterization of novel germline TP53 variants in Swedish families
    Kharaziha, Pedram
    Ceder, Sophia
    Axell, Olga
    Krall, Moritz
    Fotouhi, Omid
    Bohm, Stefanie
    Lain, Sonia
    Borg, Ake
    Larsson, Catharina
    Wiman, Klas G.
    Tham, Emma
    Bajalica-Lagercrantz, Svetlana
    CLINICAL GENETICS, 2019, 96 (03) : 216 - 225
  • [4] Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary
    Beird, Hannah C.
    Lin, Dimitri
    Lazar, Alexander J.
    Futreal, P. Andrew
    JOURNAL OF PATHOLOGY, 2024, 263 (02): : 131 - 134
  • [5] Rare Variants in TP53 and Susceptibility to Neuroblastoma
    Diskin, Sharon J.
    Capasso, Mario
    Diamond, Maura
    Oldridge, Derek A.
    Conkrite, Karina
    Bosse, Kristopher R.
    Russell, Mike R.
    Iolascon, Achille
    Hakonarson, Hakon
    Devoto, Marcella
    Maris, John M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (04):
  • [6] Germline TP53 Variants and Susceptibility to Osteosarcoma
    Mirabello, Lisa
    Yeager, Meredith
    Mai, Phuong L.
    Gastier-Foster, Julie M.
    Gorlick, Richard
    Khanna, Chand
    Patino-Garcia, Ana
    Sierrasesumaga, Luis
    Lecanda, Fernando
    Andrulis, Irene L.
    Wunder, Jay S.
    Gokgoz, Nalan
    Barkauskas, Donald A.
    Zhang, Xijun
    Vogt, Aurelie
    Jones, Kristine
    Boland, Joseph F.
    Chanock, Stephen J.
    Savage, Sharon A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
  • [7] Second Specimen Testing for TP53 Variants
    Bissonnette, J.
    Marshall, M.
    Barber, K.
    Klein, R. T.
    Zhao, J.
    Hruska, K. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 952 - 952
  • [8] Clinical management of TP53 mosaic variants found on germline genetic testing
    Ward, Abigail
    Farengo-Clark, Dana
    Mckenna, Danielle B.
    Safonov, Anton
    Good, Madeline
    Le, Anh
    Kessler, Lisa
    Shah, Payal D.
    Bradbury, Angela R.
    Domchek, Susan M.
    Nathanson, Katherine L.
    Powers, Jacquelyn
    Maxwell, Kara N.
    CANCER GENETICS, 2024, 284 : 43 - 47
  • [9] Blood functional assay for rapid clinical interpretation of germline TP53 variants
    Raad, Sabine
    Rolain, Marion
    Coutant, Sophie
    Derambure, Celine
    Lanos, Raphael
    Charbonnier, Francoise
    Bou, Jacqueline
    Bouvignies, Emilie
    Lienard, Gwendoline
    Vasseur, Stephanie
    Farrell, Michael
    Ingster, Olivier
    Desurmont, Stephanie Baert
    Kasper, Edwige
    Bougeard, Gaelle
    Frebourg, Thierry
    Tournier, Isabelle
    JOURNAL OF MEDICAL GENETICS, 2021, 58 (12) : 796 - 805
  • [10] Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants
    Schwartz, Alison N.
    Hyman, Sophie R.
    Stokes, Samantha M.
    Castillo, Danielle
    Tung, Nadine M.
    Weitzel, Jeffrey N.
    Rana, Huma Q.
    Garber, Judy E.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1677 - 1686